Patents by Inventor John C. Spinosa

John C. Spinosa has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • METHODS OF ASSESSING AND MONITORING TUMOR LOAD
    Publication number: 20220389522
    Abstract: The invention disclosed herein generally relates to methods of assessing and monitoring tumor load through analysis of tumor DNA in cancer patients. Quantitative measures derived from cell-free DNA and germline DNA are used to assess and monitor tumor load. By assessing and monitoring tumor load, cancer may be detected in a subject. The tumor load of a subject may be assessed at a number of different time points to monitor a progression, regression, or recurrence of cancer in a subject.
    Type: Application
    Filed: June 22, 2022
    Publication date: December 8, 2022
    Applicant: Lexent Bio, Inc.
    Inventors: Samuel LEVY, John C. SPINOSA
  • Methods of assessing and monitoring tumor load
    Patent number: 11408036
    Abstract: The invention disclosed herein generally relates to methods of assessing and monitoring tumor load through analysis of tumor DNA in cancer patients. Quantitative measures derived from cell-free DNA and germline DNA are used to assess and monitor tumor load. By assessing and monitoring tumor load, cancer may be detected in a subject. The tumor load of a subject may be assessed at a number of different time points to monitor a progression, regression, or recurrence of cancer in a subject.
    Type: Grant
    Filed: October 29, 2018
    Date of Patent: August 9, 2022
    Assignee: Lexent Bio, Inc.
    Inventors: Samuel Levy, John C. Spinosa
  • METHODS OF ASSESSING AND MONITORING TUMOR LOAD
    Publication number: 20190300962
    Abstract: The invention disclosed herein generally relates to methods of assessing and monitoring tumor load through analysis of tumor DNA in cancer patients. Quantitative measures derived from cell-free DNA and germline DNA are used to assess and monitor tumor load. By assessing and monitoring tumor load, cancer may be detected in a subject. The tumor load of a subject may be assessed at a number of different time points to monitor a progression, regression, or recurrence of cancer in a subject.
    Type: Application
    Filed: October 29, 2018
    Publication date: October 3, 2019
    Inventors: Samuel Levy, John C. Spinosa